BNT324 Clinical Trials

2 actively recruiting trials across 2 locations

▲ +1 trial since May 2026

Also known as: DB-1311

Pipeline

Phase 3: 1Phase 1/2: 1

Top Sponsors

BioNTech SE2

Indications

Cancer2
Advanced Lung Cancer1
Metastatic Castration-resistant Prostate Cancer1
Lung Cancer1

Phoenix, Arizona1 trial

A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

Mayo Clinic Arizona

Phase 1/2

Rockville, Maryland1 trial

A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer

Maryland Oncology Hematology

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.